We use cookies to help provide you with the best possible online experience. Please read our Privacy Policy for information about which cookies we use and what information we collect on our site. By continuing to use this site, you agree that we may store and access cookies on your device.

I Agree

You are here: Industry Insights > Class 1 new drugs

News List

A Review of Chinese-produced Class 1 New Drugs from 2018 to 2020 PharmaSources/Caicai
January 28, 2021
From 2018 to 2020, the marketing of Chinese-produced Class 1 new drugs entered the harvest period, with a total of 32 marketed (Chinese-produced Class 1 new drugs here refer to drugs registered under the classification of chemical drugs 1 and therapeutic.
Best-sellers among the 20 Chinese-produced Class 1 New Drugs Marketed Since 2018 PharmaSources/Caicai
April 21, 2020
Class 1 new drugs, Chinese-produced, marketing.According to statistics, the NMPA approved the marketing of 13 Class 1 new drugs and 17 biological products in the 17 years from 2001 to 2017. The number of innovative drugs approved was pitifully small.
New Player Joining, what will be Its Odds of Success in Marching into the Hypoglycemic Drug Market? Xiaoyaowan
January 23, 2018
New Player Joining the Chinese Class 1 New Drugs of DPP-4 Inhibitor Type, what will be Its Odds of Success in Marching into the Hypoglycemic Drug Market?